196 related articles for article (PubMed ID: 12790768)
1. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy.
Viklický O; Matl I; Voska L; Böhmová R; Jaresová M; Lácha J; Lodererová A; Stríz I; Teplan V; Vítko S
Physiol Res; 2003; 52(3):353-60. PubMed ID: 12790768
[TBL] [Abstract][Full Text] [Related]
2. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
3. Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients.
Baczkowska T; Perkowska-Ptasińska A; Sadowska A; Lewandowski Z; Nowacka-Cieciura E; Cieciura T; Pazik J; Lewandowska D; Mroz A; Urbanowicz A; Nazarewski S; Danielewicz R
Transplant Proc; 2005 Mar; 37(2):773-5. PubMed ID: 15848527
[TBL] [Abstract][Full Text] [Related]
4. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
[TBL] [Abstract][Full Text] [Related]
6. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.
Pribylova-Hribova P; Kotsch K; Lodererova A; Viklicky O; Vitko S; Volk HD; Lacha J
Kidney Int; 2006 May; 69(10):1872-9. PubMed ID: 16612332
[TBL] [Abstract][Full Text] [Related]
8. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
[TBL] [Abstract][Full Text] [Related]
9. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.
Mas V; Alvarellos T; Giraudo C; Massari P; De Boccardo G
Transplantation; 2002 Sep; 74(5):718-21. PubMed ID: 12352892
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 expression in kidney allograft protocol biopsies during cyclosporine A therapy.
Ortiz F; Helanterä IT; Räisänen-Sokolowski A; Honkanen EO; Koskinen PK
Int J Artif Organs; 2013 Jan; 36(1):56-62. PubMed ID: 23280075
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
[TBL] [Abstract][Full Text] [Related]
12. Sequential protocol biopsies from renal transplant recipients show an increasing expression of active TGF beta.
Jain S; Mohamed MA; Sandford R; Furness PN; Nicholson ML; Talbot D
Transpl Int; 2002 Dec; 15(12):630-4. PubMed ID: 12478410
[TBL] [Abstract][Full Text] [Related]
13. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene polymorphisms in kidney transplantation.
Dhaouadi T; Sfar I; Bardi R; Jendoubi-Ayed S; Abdallah TB; Ayed K; Gorgi Y
Transplant Proc; 2013; 45(6):2152-7. PubMed ID: 23747182
[TBL] [Abstract][Full Text] [Related]
15. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
Boratyńska M
Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
[TBL] [Abstract][Full Text] [Related]
16. Significance of early biopsy in pediatric kidney transplantation.
Ishimura T; Ishida T; Fujisawa M
Aktuelle Urol; 2003 Jul; 34(4):234-8. PubMed ID: 14566671
[TBL] [Abstract][Full Text] [Related]
17. beta6 integrin is up-regulated in chronic renal allograft dysfunction.
Sawada T; Abe M; Kai K; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Oct; 18(5):525-8. PubMed ID: 15344954
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML
Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
[TBL] [Abstract][Full Text] [Related]
19. Markers of fibrosis in early biopsies of renal transplants.
Palomar R; Mayorga M; Ruiz JC; Cuevas J; Rodrigo E; Cotorruelo JG; Val-Bernal JF; Arias M
Transplant Proc; 2005 Apr; 37(3):1468-70. PubMed ID: 15866642
[TBL] [Abstract][Full Text] [Related]
20. Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children.
Melk A; Henne T; Kollmar T; Strehlau J; Latta K; Offner G; Jhangri GS; Ehrich JH; Von Schnakenburg C
Kidney Int; 2003 Jul; 64(1):314-20. PubMed ID: 12787424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
